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ABSTRACT 
Phosphanegold(I) thiolates, Ph3PAu[SC(OR) = NPh], R = Me (1), Et (2) and iPr (3), were 
previously shown to be significantly cytotoxic toward HT-29 cancer cells and to induce cell 
death by both intrinsic and extrinsic apoptotic pathways whereby 1 activated the p73 gene, and 
each of 2 and 3 activated p53; 2 also caused apoptotic cell death via the c-Jun N-terminal 
kinase/mitogen-activated protein kinase pathway.  Apoptosis pathways have been further 
evaluated by mitochondrial cytochrome c measurements and annexin V screening, confirming 
apoptotic pathways of cell death.  Cell cycle analysis showed the majority of treated HT-29 
cells were arrested at the G2/M checkpoint after 24 h; results of both assays were confirmed by 
changes in populations of relevant genes (PCR array analysis).  Cell invasion studies showed 
inhibition of metastasis through Matrigel™ matrix to 17-22 % cf. untreated cells.  LC50 values 
were determined in zebrafish (8.36, 8.17, and 7.64 µM for 1–3).  Finally, the zebrafish tolerated 
doses of 1 and 2 up to 0.625 µM, and 3 was tolerated at even higher doses of up to 1.25 µM. 
 
 
Abbreviations 
Annexin V-FITC Recombinant annexin V conjugated to fluorescein isothiocyanate 
APAF-1 Apoptotic protease activating factor 1 
ATR  Ataxia telangiectasia and Rad3-related  
Bax Apoptosis regulator 
Bcl-2 B-cell lymphoma 2 
BIRC-5 Baculoviral inhibitor of apoptosis repeat-containing 5/ Survivin 
CCNB1 Cyclin B1 
cdc25C Cell division cycle 25C 
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CDKN1A Cyclin-dependent kinase N1A 
CDK2 Cyclin-dependent kinase 2 
CDK4 Cyclin-dependent kinase 4 
CHEK1/Chk1 Checkpoint kinase 1 
CHEK2/Chk2 Checkpoint kinase 2 
c-Src Proto-oncogene tyrosine-protein kinase 
dpf day(s) post fertilization 
FAK Focal adhesion kinase 
FSC Forward scatter 
GADD45 Growth arrest DNA-damage-inducible protein 45 
G1 Phase Gap-1 Phase 
G2 Phase  Gap-2 Phase/Pre-mitotic phase 
G2/M Phase Gap-2/Mitotic Phase 
hpf hour(s) post fertilization 
JNK c-Jun N-terminal kinase 
LC50 lethal concentration required to kill 50% of the population 
M Phase  Mitotic phase 
MAPK Mitogen-activated protein kinase 
MMP2 Matrix metalloproteinase-2 
MMP9 Matrix metalloproteinases-9 
NF-κB Nuclear Factor Kappa Beta 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
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PI Propidium iodide 
PS Phosphatidylserine 
p21 Potent cyclin-dependent kinase inhibitor 
p53  Tumor suppressor gene p53 
p73 Tumor suppressor gene p73 
ROS Reactive oxygen species 
S Phase Synthesis phase 
SSC Side scatter 
Tcf T-cell factor 
XIAP X chromosome-linked IAP 
 
Keywords: Gold(I) compounds; carbonimidothioates; phosphanegold(I) thiolates; apoptosis; 
HT-29 cancer cell; zebrafish 
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1.  Introduction 
Phosphanegold(I) compounds showed early promise as anticancer drugs through 
biological screening [1-8] and evaluation of mechanistic pathways [3-8].  For example, in 
recent years evidence has accumulated suggesting phosphanegold(I) compounds are 
responsible for mitochondrial dysfunction leading to cell death [3-8].  The importance of 
mitochondria as useful targets in cancer cells arises because they serve as a reservoir of proteins 
that stimulate the apoptotic death when mobilized into the cytosol [9,10].  Moreover, 
mitochondria employ both vital and lethal functions in physiological and pathological 
conditions. 
In the cell cycle checkpoint signaling cascade, mediators provide a platform for signal 
transduction, activated transducers, DNA damage sensors, and their effectors leading to cell 
cycle arrest and other necessary metabolic actions [11].  Eukaryotic cell cycle checkpoints are 
responsible for the regulation of sequential formation, activation, and subsequent inactivation 
of cyclin dependent kinases, the activation of which is dependent upon an association with 
cyclins [12].  Therefore, failing to maintain genomic integrity results in accretion of multiple 
deleterious mutations and may lead to cancer development [11].  Furthermore, deregulation of 
the cell cycle resulting in uncontrolled cell proliferation, is one of the most common alterations 
that occurs during tumor development [13].  Consequently, the blockage of the cell cycle is 
regarded as an important operative strategy for killing cancer cells [14]. 
The use of zebrafish (Danio rerio) has emerged as a powerful model system to monitor 
angiogenesis in vivo [15-17].  Zebrafish have been used as a model organism for research 
purposes for more than 20 years and therefore handling methods, optimum breeding techniques, 
husbandry, and maintenance are well established [18].  Recent research has shown that most 
of the genes found in humans have at least one zebrafish orthologue [19].  The above ensures 
zebrafish as being highly useful for the study of complex biological processes such as cell 
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senescence and apoptosis, aging, cardiovascular system development, and drug toxicity 
response [15-21].  There are a few special characteristics of zebrafish that are worth 
highlighting.  In particular, the transparency of zebrafish embryos is of great advantage as this 
allows real time assessment of organogenesis and phenotypic changes during both drug and 
toxicity trials [20].  Zebrafish embryos can absorb drugs ex vivo through their egg membrane 
or skin [21] thereby adding to their utility for drug evaluation.  This aspect has the considerable 
advantage of making it possible to treat an embryo with a drug and then to observe real time 
changes by simply employing a microscope. 
It was recently reported that Ph3PAu[SC(OR) = NPh], R = Me (1), Et (2) and iPr (3), 
exhibited significant cytotoxicity to the HT-29 cancer cell line and induced both intrinsic and 
extrinsic apoptotic pathways [22].  Specifically, it was demonstrated that 1 activates the p73 
gene in contrast to each of 2 and 3 which activate the p53 gene.  Further, an additional apoptotic 
mechanism was induced by 2, namely via the JNK/MAP pathway [22].  Given these promising 
early results, the present work continues an investigation of 1–3 by delving more deeply into 
cell apoptosis, release of cytochrome c, cell invasion, cell cycle analysis, gene expression, and 
in vivo toxicity assessment during zebrafish development. 
 
2.  Experimental 
2.1  Instrumentation for chemical analysis 
Elemental analyses were performed on a Perkin Elmer PE 2400 CHN Elemental Analyser.  1H 
and 13C{1H} NMR spectra were recorded in CDCl3 solutions on a Bruker Avance 400 MHz 
NMR spectrometer with chemical shifts relative to tetramethylsilane.  31P{1H} NMR spectra 
were recorded in CDCl3 solution on the same instrument with the chemical shifts recorded 
relative to 85% aqueous H3PO4 as the external reference.  Stock solutions of Ph3PAu{SC(OR) 
= NC6H5}, for R = Me, Et and iPr, were prepared in acetonitrile for the photoluminescence (1 
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x 10-3 M) and UV (1 x 10-5 M) measurements.  The optical absorption spectra were measured 
in the range 190–1100 nm on a single-beam Agilent Cary 60 UV-Vis spectrophotometer.  
Photoluminescence (PL) measurements were carried out on an Agilent Varian Cary Eclipse 
Fluorescence Spectrophotometer using a Xenon flash lamp as the excitation source at room 
temperature. 
 
2.2  Synthesis 
All reactions were carried out under ambient conditions.  All chemicals and solvents were 
sourced commercially and used as received.  The thiocarbamides and 
triphenylphosphanegold(I) complexes were prepared as described previously [22]. 
 
2.2.1  Ph3PAu[SC(OMe) = NC6H5] (1) 
Anal. Calc. for C26H23AuNOPS: C, 49.93; H, 3.71; N, 2.24. Found: C, 49.69; H, 3.45; N, 
2.28.  UV (acetonitrile, 1.0 x 10-5 M): λmax = 240 nm (ε = 2.3 x 103 cm-1 M-1); 267 (1.2 x 103); 
275 (1.1 x 103) nm.  PL (acetonitrile, 1 x 10-3 M, λex = 240 nm): 336, 422, 488, 533 (sh), 582 
(sh) nm. 
2.2.2  Ph3PAu[SC(OEt) = NC6H5] (2) 
Anal. Calc. for C27H25AuNOPS: C, 50.71; H, 3.94; N, 2.19. Found: C, 50.64; H, 3.75; N, 
2.26.  UV (acetonitrile, 1.0 x 10-5 M): λmax = 240 nm (ε = 2.5 x 103 cm-1 M-1); 267 (1.2 x 103); 
275 (1.0 x 103) nm.  PL (acetonitrile, 1 x 10-3 M, λex = 240 nm): 336, 422, 488, 532 (sh), 590 
(sh) nm. 
2.2.3  Ph3PAu[SC(OiPr) = NC6H5] (3) 
Anal. Calc. for C28H27AuNOPS: C, 51.46; H, 4.16; N, 2.14. Found: C, 51.31; H, 3.84; N, 
2.39.  UV (acetonitrile, 1.0 x 10-5 M): λmax = 240 nm (ε = 2.6 x 103 cm-1 M-1); 267 (1.2 x 103); 
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275 (1.0 x 103) nm.  PL (acetonitrile, 1 x 10-3 M, λex = 240 nm): 336, 422, 488, 533 (sh), 582 
(sh) nm. 
 
2.3  Mitochondrial cytochrome c measurements 
The HT-29 cells were cultured at a density of 1 x 106 cells/mL.  The cells were treated 
with the previously determined IC50 concentrations of 1–3, i.e., 11.30, 17.20, and 16.80 µM, 
respectively [22], and incubated at 37 ºC for 6, 12, and 24 h.  After harvesting, the cells were 
permeabilized, stained, and fixed according to the standard protocols (FlowCelletTM 
Cytochrome C Kit, Millipore, Germany).  The samples were then analyzed using a flow 
cytometer (FASCalibur™, BD Biosciences) equipped with BD cell-fit softwareTM; the band 
pass filter for anti-cytochrome c-FITC is 488 nm.  Each of the forward scatter (FSC) and side 
scatter (SSC) was slightly adjusted to exclude debris and cell aggregates.  The experiments 
were performed in duplicate. 
 
2.4  Flow cytometry for cell apoptosis analysis 
Cells were cultured to a density of 1 x 106 cells/mL and treated with the IC50 
concentrations of each compound, and incubated for 6 and 24 h.  1 % DMSO was the negative 
control.  After induction of apoptosis the cells were harvested and washed with ice cold PBS 
twice, and then resuspended in 500 μL of ice cold 1X binding buffer.  The treatment groups 
were stained with Annexin V-FITC and propidium iodide (PI) according to the manufacturer’s 
protocols (ApopNexinTM FITC Apoptosis Detection Kit, Chemicon, Canada).  The suspension 
was then incubated for 20 min at room temperature in the absence of light.  Calibration of the 
flow cytometer (FACSCaliburTM, BD Biosciences) was required to allow for electronic 
compensation and to determine quadrant statistics.  The cells were then sent for bi-color 
analysis (band pass filter for FITC is 530 nm and is 600 nm for PI).  Each of the FSC and SSC 
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was slightly adjusted to exclude debris and cell aggregates.  The experiments were performed 
in duplicate. 
 
2.5  Flow cytometry for cell cycle analysis 
The wells were seeded with 3 x 105 cells/mL, treated with IC50 doses of 1–3, and 
incubated for 6, 12, and 24 h.  The cells were collected after the specified incubation time and 
after washing twice with ice cold PBS, were fixed in ice cold 70 % ethanol, and then stored 
overnight at -20 oC.  Prior to cell cycle analysis each sample was washed again with ice cold 
PBS to remove excess ethanol and to rehydrate the cells.  PBS was added to resuspend the cell 
pellet, RNase A (1 mg/mL) and PI (1 mg/mL) were added followed by incubation for 30 min 
at room temperature in the dark, and placed on ice before analysis on a flow cytometer 
(FASCalibur™, BD Biosciences).  The PI fluorescence was measured at 488 nm laser 
illumination.  The number of events at each of the stages of cell cycle was expressed as a 
percentage.  The experiments were performed in duplicate. 
 
2.6  Extraction of RNA, and RT2 Profiler PCR microarray (cell cycle analysis) 
The cells were plated at a density of 3 x 106 cells per T-75 cm2 flask.  Total RNA was 
extracted from the cultured HT-29 cells using a high purity RNeasy Mini Kit (Qiagen, USA) 
according to the manufacturer’s protocol.  Total RNA samples were dissolved in 
diethylpyrocarbonate treated water and their concentration and quality were analyzed by 
electrophoresis and UV-vis spectroscopy (BioPhotometer Spectrophotometer UV/VIS, 
Eppendorf, Germany). 
The real-time PCR for microarray assay was performed using the RT2 Profiler PCR 
microarray cell cycle (PHAS-020) according to the manufacturer’s protocol (Qiagen, 
Germany).  The Human Cell Cycle RT² Profiler™ PCR Array profiles the expression of 84 
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genes key to cell cycle regulation.  This array contains genes that both positively and negatively 
regulate the cell cycle, the transitions between the each of the phases, DNA replication, 
checkpoints, and arrest.  Gene expression was compared according to the threshold cycle (Ct) 
value.  The experiments were performed in duplicate. 
 
2.7  Cell invasion assay 
The wells were prepared with a concentration of 5 x 104 cells/mL.  The experiment was 
performed by following the protocols of the BD Biosciences (San Jose, CA) MatrigelTM 
Invasion Chamber.  The cells were treated with the IC50 doses of 1–3 and incubated for 24 h.  
Non invading cells were removed from the upper surface of the membrane by gently scrubbing 
with a cotton tipped swab.  The inserts were then stained.  The cells were fixed with absolute 
methanol for 2 min, followed by staining with 1 % toluidine blue O (Sigma-Aldrich), and 
washed with PBS.  The insert was placed on a glass slide and observed under a light microscope 
with 200x magnification (Ziess, USA).  Cell counting was facilitated by photographing the 
membrane and by direct counting with the aid of cell counter.  Data were measured in triplicate 
and are shown as mean ± SEM; SEM = standard error of the mean. 
 
2.8  Zebrafish culture and embryo selection  
Adult zebrafish (Danio rerio) were obtained from the Faculty of Science and Technology, 
University of Malaysia Terengganu (Terengganu, Malaysia).  Fish were fed with commercially 
available fish food twice daily and kept at approximately 28 ºC with a 14/10 h light/dark 
photoperiod in a flow through system.  Plastic embryo collection traps were set between 4 and 
6 pm and collected the following morning within 1 h of spawning between 9 and 10 am.  
Collected embryos were placed in petri dishes containing egg water and incubated at 28 ºC 
until separated into experimental groups.  The spawning finished at the beginning of the light 
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cycle and the fertilized eggs were washed twice with fish culture medium.  The embryos were 
collected 2 h post fertilization (hpf) and examined under a stereomicroscope.  Embryos that 
had developed normally and reached the blastula stage were selected for subsequent 
experiments. 
 
2.9  Embryo testing 
First, 40 embryos were placed in 48-well plates (one embryo/well) and at 2 hpf exposed 
to different concentrations of compounds 1–3 (0.625-10.0 µM) in 0.1 % DMSO incubated in 
E3 medium (0.3 g NaCl, 0.013 g KCl, 0.05 g CaCl2, 0.08 g MgSO4, and 0.05 % methylene 
blue) at 28 ºC.  As a negative control 0.1 % DMSO treated embryos were used.  Exposures 
were carried out in duplicate (two plates).  All larvae were screened daily under a microscope 
and were examined until 3 days post fertilization (dpf).  The procedure was performed in the 
dark.  Digital images of embryos and larvae in lateral orientations were taken every day under 
a stereomicroscope at 10x magnification (Nikon Eclipse TE2000-U with ACT-1 imaging 
software).  Data for each treatment group were then merged and analyzed statistically.  
Concentration response curves were plotted for lethality from which LC50 values were 
calculated for 24 hpf.  The experiments were performed in triplicate. 
 
 
3. Results and discussion 
3.1  Synthesis and spectroscopic characterization 
Air and light stable crystalline Ph3PAu[SC(OR) = NC6H5], R = Me (1), Et (2), and iPr (3), 
were prepared in high yields as described previously [22] and following well established 
protocols [23], i.e., via the reaction of Ph3PAuCl with the respective ROC(=S)N(H)Ph ligand 
[24] in the presence of base, and exhibited the same spectroscopic (1H, 13C{1H} and 31P{1H} 
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NMR and IR) characteristics [22].  Absorption spectra recorded in acetonitrile for 1–3 were 
virtually identical presenting three bands (Table S1).  The most intense absorption was a high 
energy band centered at 240 nm which are assigned to inter-ligand pi–pi* transitions [25].  Two 
additional low energy bands with reduced intensity were observed at 267 and 275 nm.  The 
low energy band involves transitions from the phosphane to the thiolate ligand.  The remaining 
band appears to arise from transitions between the thiolate ligand and a delocalized state 
involving the entire molecule.  Photoluminescence characteristics of 1–3 were also investigated 
by exciting each sample at the three absorption maxima discussed above.  Two primary 
emission bands were observed with several weak shoulders (Table S2).  Bands were of 
maximum intensity when λex was 240 nm with the high energy bands (420-422 nm) being less 
intense than the low energy bands (486-489 nm).  The relative intensities were inverted when 
λex was 267 and 275 nm. 
 
3.2  Mitochondrial cytochrome c measurements 
The mitochondrial dependent cell death pathway contributes to the intrinsic pathway of 
apoptosis, a pathway that involves caspase-9.  Upon induction of apoptosis by 1–3, reactive 
oxygen species (ROS) will depolarize the mitochondrial membrane potential.  This leads to the 
release of cytochrome c and pro-apoptotic proteins such as pro-caspase 9 from the 
intermembrane spaces of mitochondria into the cytosol leading to an intrinsic pathway of cell 
death.  When released, cytochrome c will act with the pro-caspase 9 and apoptotic protease 
activating factor-1 (APAF-1) to activate the caspase cascade which promotes cell death [26].  
Hence, the quantification of cytochrome c release from mitochondria of apoptotic cells can be 
used as an indicator of an apoptotic pathway. 
The initial study on 1–3 [22] revealed significant expression of Bax while Bcl-2 
expression decreased.  This suggests in 1–3-induced imbalance of the Bax/Bcl-2 ratio followed 
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by dysregulation of the mitochondrial membrane potential, and the subsequent activation of 
caspase-3 which may lead to irreversible apoptosis [22].  In addition, APAF-1 was also 
significantly upregulated by 1–3.  This result is consistent with cytochrome c binding to APAF-
1 and procaspase-9 to form the apoptosome which activates the inactive procaspase-9 [22].  To 
confirm this mechanism, the cytosolic levels of cytochrome c after 6, 12 and 24 h exposure 
were analyzed, i.e., when caspase activity was at its maximum. 
The untreated cells (negative control) showed low level release of cytochrome c from the 
mitochondria of HT-29 cells as seen in the concentration of the fluorescence population at M2 
in the histograms shown in Fig. 2a.  Less than 6 % of cytochrome c was released into the 
cytoplasm after 24 h.  By contrast, the treated groups showed release of cytochrome c after as 
early as 6 h incubation as seen in the shift of the fluorescence population to M1 which arises 
as a result of binding by fluorescent anti-cytochrome c-FITC, Figs. 2b-d.  After 24 h treatment 
of 1–3 about 97-99% of cytochrome c was released. 
 
3.3  Flow cytometry for cell apoptosis analysis 
An early event in apoptosis is loss of plasma membrane asymmetry which results in the 
exposure of phosphatidylserine (PS) residues at the outer plasma membrane leaflet [27].  As 
annexin V interacts strongly and specifically with PS, the measurement of annexin V can be 
employed to monitor apoptosis.  In the untreated (negative control) samples, the majority of 
cells (99.61 %) were viable and non-apoptotic, Fig. 3a and Table 1, at 6 and 24 h.  Non-
apoptotic cells were marked as (Annexin V-PI-) as they remain the intact cell membrane.  When 
cells were treated with IC50 concentrations of 1–3 for 6 h, the percentage of (Annexin V-PI-) 
dropped to 86~87 % and further reduced to 58~61 % when the incubation time reached 24 h.  
At 24 h, there was a significant increase in the population of early apoptotic cells with (Annexin 
V+PI-), i.e., increasing from ~0.32 % to ~25 %, Figs. 3b-d and Table 1.  A slight increase in the 
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middle apoptosis stage, (Annexin V+PI+), was observed, indicating apoptosis proceeded with 
incubation time.  The cells that died by necrosis, < 15 % at 24 h, were marked with (Annexin 
V-PI+). 
 
3.4  Cell cycle analysis 
Cell cycle and control of apoptosis are the significant regulatory mechanisms of cell 
growth, development, and differentiation.  Cell cycle checkpoints guarantee the maintenance 
of genomic integrity by preventing DNA damage and incomplete DNA cells from further cell 
division.  To further confirm the nature of apoptosis induced by 1–3, the cell cycle distribution 
was determined at various times (6, 12 and 24 h) after exposure to the corresponding IC50 
values. 
As shown in Fig. 4 and Table 2, the population of untreated control cells at G2/M after 
24 h was 2.29%.  After being treated with 1–3 the number of cell significantly increased at the 
G2/M phase i.e., ca. 40 %.  This was accompanied by a significant decrease in the G1 phase cf. 
the untreated control cells, Table 2.  The G2/M checkpoint is operative in the late G2 phase and 
allows for the repair of damaged DNA in the late S or G2 phases, i.e., before proceeding to the 
mitosis (M) stage.  Hence, the G2 checkpoint functions to prevent damaged DNA being 
segregated into daughter cells.  At this checkpoint, cdc2 (CDK1) forms a complex with cyclin 
B1 (CCNB1).  The resulting cdc2-cyclin B1 complex plays a critical role in regulation of the 
G2/M phase and its inactivation inhibits the transition from the G2 to M phase [28].  The cdc2 
and cyclin B1 genes have been significantly downregulated by 1–3, Fig. 5.  In addition, the M 
phase inducer, phosphatase 3 (cdc25C), which plays an important role in the dephosphorylation 
of cdc2 leading to the activation of the cyclin B1/cdc2 complex [29], is also downregulated by 
1–3.  Moreover, phosphorylation of cdc25C on serine-216 by Chk1 or Chk2 generates a 
binding site for 14-3-3 proteins and results in the dissemination of phosphorylated cdc25C to 
15 
 
the cytoplasm and its retention there.  In the present study upon treatment with 1–3, Chk1 was 
upregulated from 12 h to 24 h by 1.81-, 2.33-, and 3.08-fold, respectively, so nuclear cdc2 
remains phosphorylated in the absence of cdc25C and the cells remain arrested in the G2 phase 
[30,31]. 
One of the important regulators of the cell cycle and a downstream target of p53 is 
CDKN1A, which encodes p21.  The expression of p21 is induced by p53 [32,33].  p21 is a 
potent cyclin-dependent kinase inhibitor that binds to and then inhibits the activity of cyclin-
CDK2 or -CDK4 complexes and thus functions as a negative regulator of cell cycle progression 
[33-35].  DNA damage or genotoxic stress induced by 1–3 activates ATR which then 
phosphorylates CHEK1 and probably p53 [36].  Upon phosphorylation, p53 is stabilized and 
activated, and subsequently induces the expression of p21Waf/CIP (CDKN1A) which inhibits 
CDK1-cyclin B1 activity, leading to G2/M arrest [36].  Compounds 1–3 upregulated CDKN1A, 
by 2.99-, 1.98- and 1.81-fold from 12 to 24 h (Fig. 5).  In the same way, the ATR gene was 
upregulated by 5.11-, 4.55-, and 5.71-fold, respectively, after 24 h. 
Stimulation of p53 expression also leads to DNA damage and results in induction of 
GADD45 [37].  Interestingly, GADD45 destabilizes the cyclin B1/cdc2 complex in vitro 
suggesting that it may mediate cyclin B1/cdc2 complex inactivation in vivo [38].  GADD45 
was significantly upregulated by 1–3, i.e., 6.43-, 7.87- and 11.42-fold, respectively, compared 
to the control (Fig. 5). 
 
3.5  Cell invasion study 
The suppression or inhibition of cancer cell migration and invasion is a crucial target of 
chemotherapy [39], with the obvious aim to reduce the chances of cancer metastasis into 
secondary organs such as the brain, lung, and liver [40].  It is recognized that the attachment 
of β-Catenin onto the T-cell factor (Tcf) of DNA leads to expression of survivin (BIRC5) and 
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consequently enhanced cell metastasis and angiogenesis [41,42].  The metastasis rate of 
colorectal cancer is high compared with other cancers because colorectal cancer cells are most 
abundant in Tcf [41,42].  As shown in Fig. 5, BIRC5 was downregulated after the 24 h 
incubation period, i.e., -2.98-, -1.76-, and -1.32-fold, respectively for 1–3. 
A cell invasion assay was performed to investigate the activity of 1–3 toward inhibition 
of metastasis of HT-29 cancer cells.  MatrigelTM invasion chamber is an endothelial like model 
for the study of the prevention of cancer cell invasion.  As illustrated in Fig. 6, 1–3 inhibited 
the invasion of HT-29 cells through MatrigelTM with rates decreased to 17.71±0.89 %, 
18.54±1.20 %, and 21.85±1.53 %, respectively compared with the negative control (normalized 
to 100%). 
Based on research by Mehrotra et al. [43], the activation of the cell motility kinases focal 
adhesion kinase (FAK) and c-Src tyrosine kinase (c-Src) by NF-κB contributes to cancer 
progression and metastasis, and the activity of NF-κB is related to survivin [59].  Activation of 
survivin is due to the mutation of WnT signaling leading to further activation of β-Catenin.  
Activated NF-κB can selectively bind DNA and leads to irregular expression of genes related 
to apoptosis, promotes cell proliferation, releases proteins needed for angiogenesis, and 
stimulates invasion and metastasis [44,45].  Thus, evidence of downregulation of survivin by 
1–3 [22] coupled with downregulation of XIAP expression, i.e., -7.28-, -3.44-, and -5.87-fold, 
respectively (Fig. 9), leads to the inhibition of metastasis in HT-29 cells. 
Other inhibition effects on NF-κB were promoted by 1–3.  The inhibition of NF-κB leads 
to further inhibition of the synthesis of metalloproteineases, MMP2 and MMP9 which regulate 
tumor invasiveness [46].  According to Fig. 5, MMP2 was significantly downregulated by 1–
3, i.e., by 6.42-, 6.79- and 7.92-fold, respectively.  The inhibition of metalloproteineases 
prevents the basement membrane of endothelial cells in blood vessels from degrading [47,48]. 
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3.6 Related complexes 
The new results complement the Ph3PAu[SC(OR) = N(p-tolyl)], R = Me (4), Et (5) and 
iPr (6), series which was shown also to induce apoptosis by extrinsic and intrinsic pathways, 
and to downregulate NF-κB [49].  Further, 4 did not upregulate p53 or p73, 5 upregulated both 
whereas 6 only upregulated p53.  This interdependence on R and the nature of the N-bound 
aryl group suggests compound specific biological activity.  Over and above the anti-cancer 
potential of 4–6, these have also proved to exhibit broad range antimicrobial activity against 
Gram positive bacteria, including against multidrug resistant strains of methicillin resistant S. 
aureus (MRSA), and to be bactericidal [50].  The foregoing suggests this class of compound is 
well worthy of further, systematic investigation for biological potential and may complement 
platinum drugs for the treatment of cancer [51]. 
 
3.7  Zebrafish embryo toxicity 
The zebrafish embryo is a useful research model to study human disease, nanoparticle 
toxicity, and drug screening because it is small, transparent, undergoes rapid embryo genesis, 
the fish continuously reproduce, and are easy to maintain [52].  Over and above these 
considerations, zebrafish embryos have a high degree of homology to the human genome, 
which ensures this living organism is useful for toxicological studies [52,53].  Representative 
images of zebrafish embryos treated with 1–3 at concentrations 0.625, 1.25, 2.5, and 5.0 µM 
are shown in Fig. 7.  The negative control (1 % DMSO) did not show mortality and 
morphological changes were as shown in Fig. 7 (top).  The percentage survival decreased with 
increasing concentrations of 1–3 as shown in Fig. 8. 
The changes in the morphology of zebrafish embryos were monitored using a 
stereomicroscope during the first 72 h of exposure.  The difference in total length of larvae 
exposed to various concentrations of 1–3 was found to be insignificant.  In the control groups, 
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no deformities were detected.  All embryos and larvae showed wild-type phenotype and 
developed normally having normal eyes, pigmentation, straight trunk and tail, and no edema at 
0.625 µM of 1–3 (Fig. 7).  When the concentration of 1 and 2 was 1.25 µM (Fig. 7a, b), the 
following observations were made: the tail length of the larvae reduced in size and tended to 
bend and the body shape was also bent. Further, slight edema and egg yolk extension 
deformation or pericardial edema were evident.  More encouraging was the observation that 
overall body shape, heart, and pericardial sac of the larvae were normal after treatment with 3 
at the same concentration (Fig. 7c), indicating 3 is less toxic in this model at 1.25 µM.  Finally, 
the LC50 at 24 hpf for 3 is 7.64 µM, lower than 1 and 2 where LC50 are 8.36 and 8.17, 
respectively.  When the concentration of 1–3 was increased from 1.25 to 5.0 µM, both poor 
pigmentation and morphological disorder were observed (Fig. 7).  At higher concentrations, 
the compounds were lethal. 
 
Conclusions 
Further physiochemical and biological investigations have been conducted on phosphanegold 
thiolates, Ph3PAu[SC(OR) = NPh], R = Me (1), Et (2) and iPr (3) which display cytotoxicity 
toward HT-29 cancer cells and to induce cell death by both intrinsic and extrinsic apoptotic 
pathways [22].  Mitochondrial cytochrome c measurements confirmed apoptotic pathways of 
cell death supported by PCR (upregulation of APAF-1).  The anti-cancer effect was associated 
with the capacity of 1–3 to trigger growth inhibition at the G2/M phase at 12 and 24 h through 
the downregulation of cdc2, cdc25C and cyclin B1 and the upregulation of p21.  Cell invasion 
studies showed inhibition of metathesis through Matrigel™ matrix to 17-22 % cf. untreated 
cells.  LC50 values were determined in zebrafish to be 8.36, 8.17, and 7.64 µM for 1–3, 
respectively.  The zebrafish tolerated doses of 1–3 up to 0.625 µM; 3 was tolerated at even 
higher doses up to 1.25 µM. 
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Table 1 
Summary of cell populations in the quadrant graphs of Fig. 3.a 
 Negative  1  2  3 
 Control (%) (%)  (%)  (%) 
 6h 24h 6h 24h 6h 24h 6h 24h 
L 99.63 99.61 86.27 58.05 86.35 61.25 87.09 58.77 
EA 0.26 0.32 3.61 25.54 8.35 25.24 8.94 24.63 
MA 0.10 0.05 2.25 2.02 2.36 1.08 1.84 2.34 
N 0.01 0.02 7.88 14.39 2.93 12.42 2.13 14.26 
 
 
a  The proportion of annexin V stained cells increased with increasing incubation time.  L = 
non apoptotic cell, EA = early apoptosis, MA = middle apoptosis, and N = necrosis. 
Table 2 
Summary of cell cycle distribution (%) in the graphs of Fig. 4. 
           Negative control   1   2   3 
 6h 12h 24h 6h 12h 24h 6h 12h 24h 6h 12h 24h 
G0/G1 94.27 94.36 94.20 65.43 59.50 40.10 69.50 52.65 37.68 67.43 59.68 41.60 
S 3.61 3.57 3.60 11.80 19.98 17.10 11.22 19.80 17.81 12.98 17.48 13.94 
G2/M 2.22 2.17 2.29 21.46 23.20 40.25 18.82 27.23 39.73 18.87 21.40 43.37 
Sub G0 0.30 0.35 0.27 0.20 0.46 2.08 0.20 0.24 4.26 0.10 0.55 1.06 
 
 
Captions to Schemes/Figures 
 
Fig. 1.  Chemical structures of the triphenylphosphanegold(I) carbonimidothioates (1–3) 
investigated herein. 
 
Fig. 2.  Histograms representing the cells stained using the FlowCellet cytochrome c kitTM after 
6, 12, and 24 h: (a) Untreated group (negative control) of HT-29 cells, (b) HT-29 cells treated 
with 11.30 µM of 1, (c) 17.00 µM of 2, and (d) 16.80 µM of 3.  Histograms in b-d show 
downward shifts (from M2 to M1) in fluorescence levels due to cytochrome c. 
 
Fig. 3.  Quadrant graphs of cell apoptosis analysis after 6 and 24 h incubation time.  Note there 
is an increasing percentage of cells undergoing apoptosis as the incubation time increases, and 
eventually they will become necrotic.  (a) Untreated cells (negative control), (b) treated with 
11.30 µM of 1, (c) 17.00 µM of 2, (d) 16.80 µM of 3. 
 
Fig. 4.  Effect on cell cycle distribution in HT-29 cells.  Cells were incubated at the respective 
IC50 doses (b) 1 [11.30 µM], (c) 2 [17.20 µM], and (d) 3 [16.80 µM], with (a) being the 
untreated group [negative control].  Cells were incubated for 6, 12, and 24 h, and the 
distribution of cell cycle was determined by the FACS Calibur method. 
 
Fig. 5.  Cell cycle gene expression level in HT-29 cell lines at 12 and 24 h compared to 
untreated cells (corresponding to value 1) after treatment with (a) 1 [11.30 µM], (b) 2 [17.20 
µM], and (c) 3 [16.80 µM] at the respective IC50 doses.  *p < 0.05. 
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Fig. 6.  Matrigel™ invasion assay showing 1–3 inhibited cell invasion.  (a) Photos were taken 
at 200x magnification, and are representative of three independent experiments.  (b) Graphical 
representation of the numbers of invaded cells per microscopic fields when treated with 1–3.  
Data were shown as mean ± SEM from three independent experiments.  *p < 0.05, compared 
to the 1 % DMSO only.  The invasion rates of 1–3 are 17.71 ± 0.89%, 18.54 ± 1.20%, and 
21.85 ± 1.53%, respectively (normalized to 100%). 
 
Fig. 7.  Morphological analysis of negative control (1 % DMSO) and toxicity of (a) 1, (b) 2, 
and (c) 3 at 0.625-5.0 µM at 3dpf. 
 
Fig. 8.  Graph representing the toxicity of 1–3 in terms of survival rate of larvae at 3dpf.  Data 
represents mean ± SD (n = 40). 
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